Peraso Seeks Shareholder Approval to Remove 20% Cap on $25M Equity Line, Potentially Diluting Existing Holders by Over 70%
PRSO is trading near its 52-week low of $0.58 (8.6% above the low) on light trading volume (0.4× avg).
Summary
Peraso's preliminary proxy asks shareholders to remove the 20% cap on its $25M equity line, enabling potentially massive dilution—over 70% at current prices—just days after a Nasdaq delisting notice and amid a going-concern warning.
Key Events · Corporate Governance and Compliance · PRSO
-
Nasdaq 20% Cap Removal Proposal
Shareholders are being asked to approve the issuance of shares exceeding 19.99% of outstanding common stock to Roth Principal Investments under the $25M equity line. At the current $0.63 stock price, fully drawing the facility would require approximately 40 million new shares, diluting existing holders by over 70%.
-
Equity Line Terms Favor Investor
Roth purchases shares at a 3–5% discount to VWAP with no floor price, creating a death-spiral dynamic: the lower the stock falls, the more shares Roth receives, accelerating dilution. The company has not yet sold any shares under the agreement.
-
Nasdaq Delisting Notice
On July 21, 2026, Peraso received a deficiency notice for failing to maintain a $1.00 minimum bid price. The company has until January 19, 2027 to regain compliance, adding urgency to the financing and potential reverse split considerations.
-
Stock Incentive Plan Increase
A proposal to add 1.5 million shares to the 2019 Plan (9.9% of outstanding) is intended to fund employee retention grants through 2027. Combined with the equity line, total potential dilution is extreme.
Analysis · PRSO · Manufacturing
Peraso is asking shareholders to approve the removal of a Nasdaq-imposed 20% cap on its $25 million committed equity facility with Roth Principal Investments. If approved, the company could issue shares far beyond the current 3.0 million share limit—at today's depressed price of $0.63, fully drawing the facility would require roughly 40 million new shares, diluting existing holders by over 70%. The proxy also seeks approval to add 1.5 million shares to its stock incentive plan, further pressuring per-share value. These requests come just days after Peraso received a Nasdaq delisting notice for a sub-$1 bid price and while the company operates under a going-concern warning. The equity line is structured as a death-spiral-style instrument: the purchase price is set at a 3–5% discount to VWAP, meaning the lower the stock goes, the more shares Roth gets, and the deeper the dilution. Without the cap removal, Peraso cannot access the full $25 million, but approving it hands Roth a blank check to own the company at a steep discount.
At the time of this filing, PRSO was trading at $0.63 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $9.4M. The 52-week trading range was $0.58 to $2.37. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.